Bob Kocher

Background

Bob Kocher, M.D., is a Partner at Venrock, where he focuses on healthcare IT and services investments ¹². He joined Venrock in 2011 after serving in the Obama administration ³².

Kocher earned his undergraduate degree from the University of Washington, where he studied political science and zoology, and his medical degree from George Washington University School of Medicine ³⁴. He completed a research fellowship with the Howard Hughes Medical Institute and the National Institutes of Health, and finished his internal medicine residency at Beth Israel Deaconess Medical Center and Harvard Medical School ⁴.

Before government service, Kocher was a Partner at McKinsey & Company, where he led McKinsey Global Institute’s healthcare economics work and the Center for United States Health System Reform ²³. From 2009 to 2010, he served as Special Assistant to President Barack Obama for Healthcare and Economic Policy on the National Economic Council, where he was one of the key architects of the Affordable Care Act, focusing on cost, quality, delivery system reform, and health IT policy ²³⁵. He also helped lead the First Lady’s “Let’s Move” childhood obesity initiative and led the formation of the Partnership for a Healthier America ⁵.

Beyond investing, Kocher is an Adjunct Professor at Stanford University School of Medicine, a Non-Resident Senior Fellow at the Leonard D. Schaeffer Center for Health Policy and Economics at USC, a Guest Scholar at the Brookings Institution, and an Advisory Board Member at the National Institute of Healthcare Management ²⁶⁷. Robert Wachter, chair of the Department of Medicine at UCSF, has described him as “probably the most influential person in Silicon Valley when it comes to health care investments” ³.

Kocher is also a co-founder of Lyra Health and Accompany Health, and served as the founding Chief Medical Officer of Devoted Health during its first year ⁸⁹¹⁰.

Stated Thesis

(Self-reported: These represent what Kocher says publicly about his investing approach. See Inferred Thesis for analysis of actual investment behavior.)

Kocher’s investment work at Venrock centers on value-based care, primary care transformation, digital health, and employer- and payer-enabled innovation ⁴. He has publicly described his focus as health technology and healthcare services investments aimed at improving affordability, quality, and access across the U.S. healthcare system ⁴.

Kocher has stated that incentive alignment is central to his investing philosophy, saying on the Twenty Minute VC podcast that healthcare investing is fundamentally about incentives ¹¹. He has emphasized that the solution in healthcare is often a workflow, not a single product, and that healthcare innovation requires understanding multiple touchpoints with patients, providers, and payers ¹¹.

On what he looks for in companies, Kocher has stated that he prioritizes solutions addressing systemic inefficiencies rather than niche problems, specifically targeting the estimated 30% waste in the U.S. healthcare system ¹¹. He has expressed that regulatory risk in healthcare is often overestimated, because regulators generally share technologists’ goals of improving productivity and reducing costs ¹¹.

On AI in healthcare, Kocher has cautioned against simplistic applications, criticizing AI chatbot pitches for mental health by saying: “They pitch it to me as a mental health improvement model. If you’re sad, anxious, or depressed, why bother with people?” ¹². He has also noted that “It is very hard to know how to smartly regulate AI since we are so early in the invention phase of the technology” ¹³.

Inferred Thesis

(Based on 14 verified investments where Kocher has a board seat or board observer role. This represents his personally led deals at Venrock, not the full Venrock portfolio. Sample size is moderate; qualitative patterns are more reliable than precise percentages.)

Sector focus: Kocher’s portfolio is exclusively healthcare. Within that, the concentration is on value-based care and care delivery (Aledade, Devoted Health, Accompany Health — 3 of 14, 21%), digital health platforms (Lyra Health, Virta Health, Grand Rounds/Included Health, Doctor on Demand — 4 of 14, 29%), healthcare infrastructure and operations (Candid Health, SmithRx, Stride Health, Suki — 4 of 14, 29%), and insurance/payer innovation (Devoted Health, Premera Blue Cross — 2 of 14, 14%).

Stage distribution: Kocher has been involved from Seed through growth stages. Based on his board companies’ first Venrock investment rounds: Seed investments include Aledade (2014), Devoted Health (2017), Virta Health (2014), and Lyra Health (2015). Series A investments include Stride Health (2015), Doctor on Demand (2013 seed then led Series A), and Suki (2018). This suggests a predominantly early-stage focus with approximately 7 of 14 (50%) at Seed or Series A, consistent with Venrock’s overall stage focus.

Geographic concentration: Based on available data, portfolio companies are concentrated in major U.S. metro areas, with a strong San Francisco Bay Area presence (Lyra Health, Grand Rounds, Virta Health, Stride Health, Suki are all Bay Area-based). Devoted Health is based in Waltham, MA, and Aledade in Bethesda, MD.

Founder profile patterns: Kocher appears to favor founders with deep domain expertise in healthcare. Notable examples include Farzad Mostashari (former National Coordinator for Health IT) at Aledade, Todd and Ed Park (former Athenahealth executives) at Devoted Health, and David Ebersman (former CFO of Facebook/Meta) at Lyra Health. Several portfolio companies were co-founded by Kocher himself (Lyra Health, Accompany Health), and he served as founding CMO at Devoted Health, indicating an unusually hands-on, operator-investor model.

Co-investor patterns: Bryan Roberts, Kocher’s fellow Partner at Venrock, appears across multiple deals. Greylock Partners appears as co-investor in both Lyra Health and Grand Rounds. Other recurring co-investors include NEA (Stride Health), Caffeinated Capital (Virta Health), and ARCH Venture Partners (Accompany Health).

Notable pattern — operator-investor hybrid: Unlike most VCs, Kocher is a physician and former policymaker who takes operational roles at portfolio companies. He co-founded Lyra Health and Accompany Health, and served as founding CMO of Devoted Health. This is a distinctive pattern that goes well beyond typical board involvement.

Notable gap: Despite the stated thesis around employer-enabled innovation, the portfolio leans more heavily toward care delivery and provider-side companies than employer-focused tools.

Portfolio

This table represents Kocher’s board and board observer positions at Venrock portfolio companies. It does not capture the full set of Venrock healthcare investments he may have been involved in. Companies marked “–” for year and stage could not be independently verified with specific round data.

In Their Own Words

“Each day I wake up and say, can we make healthcare suck a little less today?” — Bob Kocher, FREOPP profile ³.

“Probably the most rewarding part of venture investing is tackling difficult problems with great people (and then succeeding…). Devoted Health is a textbook case.” — Bob Kocher, Better Healthcare Sooner blog, October 2018 ⁹.

“It is undeniable that brothers Ed and Todd Park are uniquely capable entrepreneurs, combining distinctive healthcare knowledge, technology skills, inspirational leadership and impeccable values, with a determination to succeed.” — Bob Kocher, Better Healthcare Sooner blog, October 2018 ⁹.

“At this point in our relationship, any project in which they are interested, we are too.” — Bob Kocher on Todd and Ed Park, Better Healthcare Sooner blog, October 2018 ⁹.

“It all started with the idea, ‘how can we create a health system that treats every member like a family member?’ It turns out that you can and it is called Devoted Health. Thankfully, people achieve better outcomes & higher NPS. Exactly what you would hope for your mom or dad.” — Bob Kocher, X/Twitter post, October 2021 ²².

“All hospitals are screwed up. Nobody has figured out how to pay for healthcare in a way that makes it awesome, efficient and good.” — Bob Kocher, Vital Signs Health Substack interview ²³.

“Healthcare has to get rid of, hopefully seven of those nine people on admin as fast as it can, if it ever wants to have lower prices and higher margins.” — Bob Kocher, Vital Signs Health Substack interview ²³.

“Accompany Health has assembled a world-class team with a deep dedication to serving those most in need — and with the experience with technology and care delivery to get it done.” — Bob Kocher, Accompany Health press release, January 2024 ¹⁰.

What Founders Say

No independently sourced founder testimonials found. Kocher’s portfolio founders (Farzad Mostashari of Aledade, Todd Park of Devoted Health, David Ebersman of Lyra Health) have appeared on podcasts and in interviews alongside Kocher, but no direct founder quotes about their experience working with Kocher as an investor were found in publicly available sources.

Connections

• Board member, Aledade — alongside Farzad Mostashari (CEO), Bryan Roberts (Venrock) ¹⁴²⁴
• Board member, Devoted Health — alongside Todd Park (Co-Founder & Executive Chairman), Ed Park (CEO); served as founding Chief Medical Officer ⁹²⁰
• Board member and Co-Founder, Lyra Health — alongside David Ebersman (CEO, former Meta CFO), Bryan Roberts (Venrock) ⁸¹⁸
• Board member, Virta Health — Venrock seed investor ¹⁵¹
• Board member and Co-Founder, Accompany Health — alongside Dr. Rahul Rajkumar (CEO), Bryan Roberts (Venrock) ¹⁰
• Board member, Premera Blue Cross ¹
• Board observer, Suki — AI clinical assistant company ¹²¹
• Board observer, SmithRx ¹
• Board observer, Stride Health ¹¹⁹
• Adjunct Professor, Stanford University School of Medicine ²⁶
• Non-Resident Senior Fellow, USC Schaeffer Center for Health Policy and Economics ⁶⁷
• Guest Scholar, Brookings Institution ³
• Former Special Assistant to the President, Obama White House (2009-2010) ⁵
• Former Partner, McKinsey & Company ²³

Sources